OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Enhancing these processes involves modifying various variables, including cell line engineering, media formulation, and bioreactor settings. A key goal is to increase antibody titer while minimizing production costs a